The relationship between blood parameters related to lymphocytes in response to the treatment of idiopathic granulomatous mastitis

Document Type : Original Article

Authors

1 Professor, Department of Surgery, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

2 Medical student, Student Research Committee, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Abstract

Introduction: Granulomatous inflammatory lesions of the breast can be considered as primary or idiopathic inflammation of the breast; therefore, investigating the relationship between inflammatory parameters including neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio can be useful in the prognosis of idiopathic granulomatous mastitis. The present study was conducted with aim to investigate the relationship between blood parameters related to lymphocytes in response to the treatment of idiopathic granulomatous mastitis (IGM).
Methods: This prospective cohort study was conducted in 2020 on 34 patients with IGM referred to the breast clinic of Kurdistan University of Medical Sciences. The course of lymphocyte parameters with disease symptoms, diagnostic and treatment process were measured. For patients with a definite diagnosis of IGM, if there was a mass, aspiration was performed under ultrasound guidance, and needle sampling and routine tests, including complete blood count were performed. The evaluation time was at the beginning of the diagnosis, one month and 6 months after the complete blood count. Data analysis was done using SPSS statistical software (version 24) and variance analysis and Tukey tests. P<0.05 was considered significant.
Results: There was no significant difference between the demographic variables of age and body mass index with the treatment outcome in the examined patients (P>0.05). Also, no significant relationship was observed between the variables of mass number, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with the treatment outcome in the examined patients (P>0.05).
Conclusion: According to the results, it can be said that referring to the mean ratio of neutrophil to lymphocyte and platelet to lymphocyte is not a reliable indicator to evaluate the response to the treatment of IGM.

Keywords

Main Subjects

References

  1. Patel RA, Strickland P, Sankara IR, Pinkston G, Many W, Rodriguez M. Idiopathic granulomatous mastitis: case reports and review of literature. Journal of general internal medicine 2010; 25:270-3.
  2. Özel L, Ünal A, Ünal E, Kara M, Erdoğdu E, Krand O, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surgery today 2012; 42:729-33.
  3. Pandey TS, Mackinnon JC, Bressler L, Millar A, Marcus EE, Ganschow PS. Idiopathic granulomatous mastitis—a prospective study of 49 women and treatment outcomes with steroid therapy. The breast journal 2014; 20(3):258-66.
  4. Atak T, Sagiroglu J, Eren T, Ali Özemir İ, Alimoglu O. Strategies to treat idiopathic granulomatous mastitis: retrospective analysis of 40 patients. Breast disease 2015; 35(1):19-24.
  5. Altintoprak F, Karakece E, Kivilcim T, Dikicier E, Cakmak G, Celebi F, et al. Idiopathic granulomatous mastitis: an autoimmune disease?. The Scientific World Journal 2013; 2013.
  6. Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World Journal of Clinical Cases: WJCC 2014; 2(12):852.
  7. Seo HR, Na KY, Yim HE, Kim TH, Kang DK, Oh KK, et al. Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis. Journal of breast cancer 2012; 15(1):111-8.
  8. Cheng J, Du YT, Ding HY. Granulomatous lobular mastitis: a clinicopathologic study of 68 cases. Zhonghua Bing li xue za zhi= Chinese Journal of Pathology 2010; 39(10):678-80.
  9. Boufettal H, Essodegui F, Noun M, Hermas S, Samouh N. Idiopathic granulomatous mastitis: a report of twenty cases. Diagnostic and interventional imaging 2012; 93(7-8):586-96.
  10. Yildiz S, Aralasmak A, Kadioglu H, Toprak H, Yetis H, Gucin Z, et al. Radiologic findings of idiopathic granulomatous mastitis. Medical Ultrasonography 2015; 17(1):39-44.
  11. Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC cardiovascular disorders 2016; 16(1):1-6.
  12. Pan L, Du J, Li T, Liao H. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu’s arteritis: a case-control study. BMJ open 2017; 7(4):e014451.
  13. Yılmaz TU, Gürel B, Güler SA, Baran MA, Erşan B, Duman S, et al. Scoring idiopathic granulomatous mastitis: an effective system for predicting recurrence?. European journal of breast health 2018; 14(2):112.
  14. Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators of inflammation 2016; 2016.
  15. Naess A, Nilssen SS, Mo R, Eide GE, Sjursen H. Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection 2017; 45:299-307.
  16. Oh GH, Chung SP, Park YS, Hong JH, Lee HS, Chung HS, et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches 2017; 47(3):323-30.
  17. Zheng CF, Liu WY, Zeng FF, Zheng MH, Shi HY, Zhou Y, et al. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Critical Care 2017; 21:1-11.
  18. Zheng J, Cai J, Li H, Zeng K, He L, Fu H, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review. Cellular Physiology and Biochemistry 2017; 44(3):967-81.
  19. Kaviani A, Vasigh M, Zand S. Idiopathic Granulomatosis Mastitis, Time to a Paradigm Change in Treatment. Iranian Quarterly Journal of Breast Disease 2020; 13(2):69-73.
  20. Martinez‐Ramos D, Simon‐Monterde L, Suelves‐Piqueres C, Queralt‐Martin R, Granel‐Villach L, Laguna‐Sastre JM, et al. Idiopathic granulomatous mastitis: A systematic review of 3060 patients. The breast journal 2019; 25(6):1245-50.
  21. Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. Journal of the American College of Surgeons 2008; 206(2):269-73.
  22. Azizi A, Prasath V, Canner J, Gharib M, Sadat Fattahi A, Naser Forghani M, et al. Idiopathic granulomatous mastitis: Management and predictors of recurrence in 474 patients. The breast journal 2020; 26(7):1358-62.
  23. Çetinkaya ÖA, Çelik SU, Terzioğlu SG, Eroğlu A. The predictive value of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with recurrent idiopathic granulomatous mastitis. European Journal of Breast Health 2020; 16(1):61.
  24. Ciftci AB, Bük ÖF, Yemez K, Polat S, Yazıcıoğlu İM. Risk factors and the role of the albumin-to-globulin ratio in predicting recurrence among patients with idiopathic granulomatous mastitis. Journal of Inflammation Research 2022: 5401-12.
  25. Bouton ME, Jayaram L, O'Neill PJ, Hsu CH, Komenaka IK. Management of idiopathic granulomatous mastitis with observation. The American Journal of Surgery 2015; 210(2):258-62.
  26. Chirappapha P, Thaweepworadej P, Supsamutchai C, Biadul N, Lertsithichai P. Idiopathic granulomatous mastitis: A retrospective cohort study between 44 patients with different treatment modalities. Annals of medicine and surgery 2018; 36:162-7.
  27. Kadivar M, Rashidian S, Jolaii A, Dabiran S. The frequency of idiopathic granulomatous mastitis and the underlying factors in recent 5-year period. Razi Journal of Medical Sciences 2016; 23(143):19-26.
  28. Baslaim MM, Khayat HA, Al-Amoudi SA. Idiopathic granulomatous mastitis: a heterogeneous disease with variable clinical presentation. World journal of surgery 2007; 31:1677-81.
  29. Uysal E, Soran A, Sezgin E, Granulomatous Mastitis Study Group. Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study?. ANZ journal of surgery 2018; 88(6):635-9.
  30. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine 2018; 97(26).
  31. Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Research 2017; 19:1-13.
  32. Kayahan M, Kadioglu H, Muslumanoglu M. Management of patients with granulomatous mastitis: analysis of 31 cases. Breast Care 2012; 7(3):226-30.
  33. Néel A, Hello M, Cottereau A, Graveleau J, De Faucal P, Costedoat-Chalumeau N, et al. Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study. QJM: An International Journal of Medicine 2013; 106(5):433-41.
  34. Omranipour R, Mohammadi SF, Samimi P. Idiopathic granulomatous lobular mastitis-report of 43 cases from iran; introducing a preliminary clinical practice guideline. Breast care 2013; 8(6):439-43.
  35. Lei X, Chen K, Zhu L, Song E, Su F, Li S. Treatments for idiopathic granulomatous mastitis: systematic review and meta-analysis. Breastfeeding Medicine 2017; 12(7):415-21.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 26, Issue 9
November 2023
Pages 10-19

Files

Share

How to cite

Statistics